Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma.

ABSTRACT:

SUBMITTER: Deng J 

PROVIDER: S-EPMC7481646 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature